Remove Drug Pricing Remove Events Remove Insurance Coverage and Processing
article thumbnail

Bolstering Health Technology Assessment With the Help of AI

Pharmaceutical Commerce

Artificial intelligence addresses key limitations of traditional health technology assessments—such as data gaps and time-intensive processes—through automation, real-time data integration, and advanced predictive modeling, leading to faster and more informed decisions. AI supports personalized medicine and real-world evidence integration.

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Building Intelligent Pharma Supply Chain Management with Real-World Data

Pharmaceutical Commerce

In some cases, these events might be entirely unpredictable, forcing them to adapt product strategies with little to no advanced preparation. They also experience some of the same problems that manufacturers and distributors face, like spotty tracking information due to the manual processes associated with barcode scanning of drugs.

article thumbnail

Policy Whiplash? 24 Hours in the Hub Still Matters More

Pharmaceutical Commerce

With ongoing policy uncertainty, hubs must prioritize adaptable, resilient designs—focusing on process speed, modularity, data tracking, and selecting partners who can evolve with regulatory change. Future-Proofing Hubs is a Must.

article thumbnail

DoH and Children’s National Hospital link for cell and gene therapy

Pharmaceutical Technology

This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. How will RFK Jr’s American dream for vaccines play out? Don’t let policy changes catch you off guard.

article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

FDA removes safety programme for CAR-T therapies to boost uptake

Pharmaceutical Technology

Adverse event reporting for CRS and neurological toxicity have remained stable,” the agency said in a statement. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. How will RFK Jr’s American dream for vaccines play out? Topic sponsors are not involved in the creation of editorial content.